Viewing Study NCT00944918


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-03-03 @ 12:43 AM
Study NCT ID: NCT00944918
Status: COMPLETED
Last Update Posted: 2011-08-29
First Post: 2009-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module